Jane Street’s Third Harmonic Bio THRD Stock Holding History

Jane Street’s Portfolio THRD Stock Details THRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,900	Closed	-$103K	–	11774
2025 Q2	$103K	Buy	+18,900	New	+$94.3K	﹤0.01%	8937

Other funds holding THRD

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

MIM

MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jane Street's THRD Position: Q2 2025 in Review

Jane Street sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 23,876 shares — an estimated $119K sold.

Jane Street first reported a position in THRD in Q3 2022 and held it in 6 quarters. The position peaked at $357K in Q3 2022. 106 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

Jane Street reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
Jane Street sold 23,876 Third Harmonic Bio shares in Q2 2025, an estimated $119K.
Jane Street first reported a position in Third Harmonic Bio in Q3 2022 and held it in 6 quarters.
Jane Street's Third Harmonic Bio position peaked at $357K in Q3 2022.
106 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.